By Jessica Tyner  |  April 2, 2014

Category: Legal News

Yaz birth control lawsuitThousands of women have sued Bayer over injuries they suffered from blood clots caused by the birth control pills Yaz and Yasmin. Two new women have joined the litigation against Bayer by filing a joint Yaz lawsuit on March 27.

Plaintiffs Denise Volwiler and Priscilla Alexander both share similar stories to many others who have filed similar cases and joined a Yaz class action lawsuit investigation.

Blood clots and oral contraception have been linked for years, but when Bayer released Yasmin in the early 2000s, it was marketed as a safer “fourth generation” form of birth control and didn’t have the same warnings for blood clots as the third generation birth control pills from the 1990s.

This is the issue, according to the many Yasmin blood clot victims. In some cases, uses of Yaz can be deadly and there are reports of women as young as 17 dying from Yaz side effects.

Signs of a blood clot can be non-existent, which is what makes them so dangerous. In April 2002, the British Medical Journal reported that the Dutch College of General Practitioners recommended that older second generation birth control pills be prescribed in lieu of Yaz as a result of 40 cases of venous thrombosis among women taking Yaz.”

A Hidden History?

In their Yaz lawsuit, both women claim that “Defendants knew or should have known that use of Yasmin created a higher risk of personal injury than other oral contraceptives on the market, including but not limited to second generation oral contraceptives, and that, when taken as directed, such use was unreasonably dangerous to consumers.” However, they allege that the birth control pill was so popular that Bayer didn’t want to risk lost profits.

Worse, according to the Yasmin lawsuit: “Despite the fact that Defendants knew or should have known of the serious health risks associated with the use of Yasmin, Defendants failed to warn Plaintiff and/or her health care providers of said serious risks before she used the product. Had Plaintiff and/or her heath care providers known the risks and dangers associated with Yasmin, she would not have used Yasmin and would not have suffered from bilateral pulmonary emboli, recurrent pulmonary embolism and a deep vein thrombosis.”

They are suing Bayer for defective manufacturing, design defect, defect due to inadequate warning, negligence, negligent misrepresentation, breach of warranties, fraudulent misrepresentation, fraudulent concealment, fraud and deceit, and violation of the Nebraska Consumer Protection Act.

The Yaz Lawsuit is Denise Volwiler and Priscilla Alexander v. Bayer Healthcare Pharmaceuticals Inc., MDL No. 2100, in the U.S. District Court Southern District of Illinois.

Do You Have a Similar Yaz Story?

If you suffered a clot or related injury while on this pill, you might have a Yasmin legal claim. Find out more when visiting the Birth Control Lawsuits: Yaz, Yasmin, Beyaz, Gianvi, Ocella Class Action Lawsuit Investigation. Submit your information and an attorney will be in touch if you qualify for a Yasmin claim review.

 

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.